DK1987026T3 - Aminoacyl-prodrugderivater og lægemidler til behandling af thromboemboliske sygdomme - Google Patents

Aminoacyl-prodrugderivater og lægemidler til behandling af thromboemboliske sygdomme

Info

Publication number
DK1987026T3
DK1987026T3 DK07703379T DK07703379T DK1987026T3 DK 1987026 T3 DK1987026 T3 DK 1987026T3 DK 07703379 T DK07703379 T DK 07703379T DK 07703379 T DK07703379 T DK 07703379T DK 1987026 T3 DK1987026 T3 DK 1987026T3
Authority
DK
Denmark
Prior art keywords
treatment
drugs
prodrug derivatives
thromboembolic diseases
diseases
Prior art date
Application number
DK07703379T
Other languages
Danish (da)
English (en)
Inventor
Hans-Georg Lerchen
Ursula Krenz
Karl-Heinz Schlemmer
Elisabeth Perzborn
Joerg Keldenich
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of DK1987026T3 publication Critical patent/DK1987026T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
DK07703379T 2006-02-16 2007-02-06 Aminoacyl-prodrugderivater og lægemidler til behandling af thromboemboliske sygdomme DK1987026T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006007146A DE102006007146A1 (de) 2006-02-16 2006-02-16 Aminoacyl-Prodrugs
PCT/EP2007/001135 WO2007093328A1 (de) 2006-02-16 2007-02-06 Aminoacyl-prodrug derivate und arzneimittel zur behandlung von thromboembolischen erkrankungen

Publications (1)

Publication Number Publication Date
DK1987026T3 true DK1987026T3 (da) 2009-11-02

Family

ID=38179935

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07703379T DK1987026T3 (da) 2006-02-16 2007-02-06 Aminoacyl-prodrugderivater og lægemidler til behandling af thromboemboliske sygdomme

Country Status (23)

Country Link
US (2) US8101601B2 (xx)
EP (1) EP1987026B1 (xx)
JP (1) JP5225864B2 (xx)
KR (1) KR20080094696A (xx)
CN (1) CN101384585B (xx)
AT (1) ATE440839T1 (xx)
AU (1) AU2007214766B2 (xx)
BR (1) BRPI0708064A2 (xx)
CA (1) CA2642376C (xx)
CY (1) CY1109375T1 (xx)
DE (2) DE102006007146A1 (xx)
DK (1) DK1987026T3 (xx)
ES (1) ES2330689T3 (xx)
HK (1) HK1130252A1 (xx)
HR (1) HRP20090629T1 (xx)
IL (1) IL192987A0 (xx)
PL (1) PL1987026T3 (xx)
PT (1) PT1987026E (xx)
RS (1) RS51190B (xx)
RU (1) RU2435768C2 (xx)
SI (1) SI1987026T1 (xx)
WO (1) WO2007093328A1 (xx)
ZA (1) ZA200806891B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II
DE102007032347A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
DE102007032345A1 (de) * 2007-07-11 2009-01-15 Bayer Healthcare Ag Aminoacyl-Prodrugs
CN101875655B (zh) * 2009-04-28 2012-05-09 天津药物研究院 氨基苯甲酸衍生物及其制备方法和用途
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof
US8971019B2 (en) 2012-03-16 2015-03-03 Avx Corporation Wet capacitor cathode containing an alkyl-substituted poly(3,4-ethylenedioxythiophene)
CN102746287B (zh) * 2012-06-21 2014-05-28 成都苑东药业有限公司 一种恶唑烷酮化合物及其制备方法
BR112015011033A2 (pt) 2012-12-26 2017-07-11 Wanbury Ltd derivado aldeído de oxazolidinonas substituídas
ES2610020T3 (es) 2012-12-26 2017-04-25 Wanbury Limited Producto intermedio de rivaroxabán y preparación del mismo
CN114384185A (zh) * 2022-01-20 2022-04-22 北京航空航天大学 用于检测γ-氨基丁酸含量的试剂在制备诊断静脉流出障碍性疾病的试剂盒中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02000294A (es) * 1999-06-25 2002-06-21 Vertex Pharma Profarmacos de carbamatos inhibidores de impdh.
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
JP2005520782A (ja) 2001-07-12 2005-07-14 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー 向上した水溶解度を有するアミド含有化合物およびアミド含有化合物の水溶解度を向上させる方法
US7265140B2 (en) 2003-09-23 2007-09-04 Pfizer Inc Acyloxymethylcarbamate prodrugs of oxazolidinones
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004002044A1 (de) 2004-01-15 2005-08-04 Bayer Healthcare Ag Herstellverfahren
DE102004062475A1 (de) 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
DE102005047558A1 (de) 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102006039589A1 (de) * 2006-08-24 2008-03-06 Bayer Healthcare Ag Aminoacyl-Prodrugs II

Also Published As

Publication number Publication date
HRP20090629T1 (hr) 2010-01-31
DE102006007146A1 (de) 2007-08-23
PL1987026T3 (pl) 2010-03-31
DE502007001402D1 (de) 2009-10-08
RS51190B (sr) 2010-10-31
CA2642376A1 (en) 2007-08-23
US8334284B2 (en) 2012-12-18
IL192987A0 (en) 2009-02-11
JP2009526788A (ja) 2009-07-23
ES2330689T3 (es) 2009-12-14
RU2435768C2 (ru) 2011-12-10
AU2007214766B2 (en) 2013-05-02
CY1109375T1 (el) 2014-07-02
WO2007093328A1 (de) 2007-08-23
ZA200806891B (en) 2010-02-24
RU2008136769A (ru) 2010-03-27
KR20080094696A (ko) 2008-10-23
AU2007214766A1 (en) 2007-08-23
CN101384585B (zh) 2012-09-26
US20110034453A1 (en) 2011-02-10
US8101601B2 (en) 2012-01-24
JP5225864B2 (ja) 2013-07-03
SI1987026T1 (sl) 2010-01-29
BRPI0708064A2 (pt) 2011-05-17
EP1987026A1 (de) 2008-11-05
PT1987026E (pt) 2009-10-30
ATE440839T1 (de) 2009-09-15
EP1987026B1 (de) 2009-08-26
US20120088761A1 (en) 2012-04-12
CN101384585A (zh) 2009-03-11
HK1130252A1 (en) 2009-12-24
CA2642376C (en) 2014-08-12

Similar Documents

Publication Publication Date Title
DK1987026T3 (da) Aminoacyl-prodrugderivater og lægemidler til behandling af thromboemboliske sygdomme
BRPI0519376A2 (pt) formas de administraÇço farmacÊuticas sàlidas, aplicÁveis por via oral, contendo rivaroxaban com liberaÇço modificada
DK1934208T3 (da) Ny polymorf form af 5-chlor-N-({(5S)-2-0x0-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
ATE545645T1 (de) Neue cokristall-verbindung von rivaroxaban und malonsäure
ECSP066584A (es) Procedimiento para la producción de una composición farmacéutica sólida de administración oral
CY1112565T1 (el) Μεθοδος παραγωγης
MX2009001977A (es) Derivados profarmacologicos de aminoacilo y medicamentos para el tratamiento de enfermedades tromboembolicas.
CR20150001A (es) Formas de administración farmacéuticas que comprenden 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil) fenil]-1,3-oxazolidin-5-il}metil)-2-tiofencarboxamida
PH12015501625A1 (en) Aldehyde derivative of substitute oxazolidinones
WO2012080184A3 (de) Flüssige, oral applizierbare pharmazeutische zusammensetzungen enthaltend 5-chlor-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
UA94428C2 (xx) Поліморфна форма та аморфна форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолініл)феніл]-1,3-оксазолідин-5-іл}метил)-2-тіофенкарбоксаміду[полиморфная форма и аморфная форма 5-хлор-n-({(5s)-2-оксо-3-[4-(3-оксо-4-морфолинил)фенил]-1,3-оксазолидин-5-ил}метил)-2-тиофенкарбоксамида
UY29305A1 (es) Formas de dosificación farmacéutica sólidas administrables por vía oral con liberación modificada
CU23445A3 (es) Procedimiento de preparación
CU20070150A7 (es) Formas de dosificacion farmacéutica sólidas administrables por vía oral con liberación modificada
DOP2004001066A (es) Procedimiento de preparacion
UY28628A1 (es) Procedimiento para la preparación de una composición farmacéutica sólida administrable oralmente